Clearside Biomedical Inc (CLSD)
1.02
-0.03
(-2.86%)
USD |
NASDAQ |
Nov 21, 16:00
1.03
+0.01
(+0.98%)
After-Hours: 20:00
Clearside Biomedical Revenue (Quarterly): 1.038M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.038M |
| June 30, 2024 | 0.09M |
| March 31, 2024 | 0.23M |
| December 31, 2023 | 6.345M |
| September 30, 2023 | 0.859M |
| June 30, 2023 | 1.018M |
| March 31, 2023 | 0.004M |
| December 31, 2022 | 0.33M |
| September 30, 2022 | 0.266M |
| June 30, 2022 | 0.384M |
| March 31, 2022 | 0.347M |
| December 31, 2021 | 25.69M |
| September 30, 2021 | 3.074M |
| June 30, 2021 | 0.78M |
| March 31, 2021 | 0.034M |
| December 31, 2020 | 0.011M |
| September 30, 2020 | 3.432M |
| June 30, 2020 | 0.354M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.097M |
| December 31, 2019 | 1.942M |
| September 30, 2019 | 0.141M |
| June 30, 2019 | 0.045M |
| March 31, 2019 | 0.045M |
| December 31, 2018 | 0.03M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.055M |
| September 30, 2017 | 0.155M |
| June 30, 2017 | 0.13M |
| March 31, 2017 | 0.005M |
| December 31, 2016 | 0.005M |
| September 30, 2016 | 0.005M |
| June 30, 2016 | 0.005M |
| March 31, 2016 | 0.505M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.004M
Minimum
Mar 2023
25.69M
Maximum
Dec 2021
2.516M
Average
0.582M
Median
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.688M |
| Total Expenses (Quarterly) | 6.972M |
| EPS Diluted (Quarterly) | -0.10 |
| Enterprise Value | 53.77M |
| Profit Margin (Quarterly) | -740.7% |
| Earnings Yield | -44.12% |
| Normalized Earnings Yield | -44.12 |